GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3626 - 3650 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgG Patient 4 12 mild
G96865DJ
1236
IgG Patient 3 11 mild
G71469XA
1239
IgM Patient 2 3 mild
G21675ZL
1242
IgA Patient 2 3 mild
G47362BJ
1245
IgM Patient 3 11 mild
G09482NW
1248
IgM Patient 3 4 mild
G82096UQ
1249
IgM Patient 2 24 mild
G71142DF
1252
IgG Patient 2 15 mild
G41200QS
1253
IgG Patient 2 24 mild
G21290RB
1256
IgA Patient 3 11 mild
G64669AQ
1265
IgA Patient 2 3 mild
G22768VO
1272
IgM Patient 3 11 mild
G16579HJ
1272
IgA Patient 2 3 mild
G00066MO
1275
IgM Patient 3 4 mild
G90562PB
1276
IgG Patient 2 15 mild
G21290RB
1278
IgA Patient 2 24 mild
G76355TG
1279
IgM Patient 3 4 mild
G42666HT
1284
IgM Patient 4 12 mild
G42346AP
1284
IgG Patient 2 3 mild
G60761LT
1304
IgA Patient 1 6 moderate
G49108TO
1308
IgA Patient 3 4 mild
G00068MO
1310
IgM Patient 1 10 moderate
G43534QA
1315
IgM Patient 2 24 mild
G00057MO
1330
IgG Patient 3 4 mild
G37036SF
1331
IgM Patient 4 12 mild
G60761LT
1336

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024